These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 18332915
41. Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma. Ladetto M, Pagliano G, Ferrero S, Cavallo F, Drandi D, Santo L, Crippa C, De Rosa L, Pregno P, Grasso M, Liberati AM, Caravita T, Pisani F, Guglielmelli T, Callea V, Musto P, Cangialosi C, Passera R, Boccadoro M, Palumbo A. J Clin Oncol; 2010 Apr 20; 28(12):2077-84. PubMed ID: 20308672 [Abstract] [Full Text] [Related]
42. [Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group]. Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J. Vnitr Lek; 2001 Sep 20; 47 Suppl 1():40-7. PubMed ID: 11693062 [Abstract] [Full Text] [Related]
46. Prolonged overall survival with second on-demand autologous transplant in multiple myeloma. Elice F, Raimondi R, Tosetto A, D'Emilio A, Di Bona E, Piccin A, Rodeghiero F. Am J Hematol; 2006 Jun 20; 81(6):426-31. PubMed ID: 16680735 [Abstract] [Full Text] [Related]
51. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L, Adam Z, Mayer J, Vorlicek J. Bone Marrow Transplant; 2005 Jan 20; 35(2):159-64. PubMed ID: 15543200 [Abstract] [Full Text] [Related]
52. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival. Jimenez-Zepeda VH, Mikhael J, Winter A, Franke N, Masih-Khan E, Trudel S, Chen C, Kukreti V, Reece DE. Biol Blood Marrow Transplant; 2012 May 20; 18(5):773-9. PubMed ID: 22062804 [Abstract] [Full Text] [Related]
53. Thalidomide, cyclophosphamide and dexamethasone induction therapy: feasibility for myeloma patients destined for autologous stem cell transplantation. Chang WJ, Kang ES, Lee ST, Kim SH, Kim DW, Kim SJ, Kim K. Acta Haematol; 2014 May 20; 132(2):226-32. PubMed ID: 24732093 [Abstract] [Full Text] [Related]
55. Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin. Holmberg LA, Becker PS, Bensinger W. Acta Haematol; 2017 May 20; 137(3):123-131. PubMed ID: 28355602 [Abstract] [Full Text] [Related]
56. BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma. Talamo G, Claxton DF, Dougherty DW, Ehmann CW, Sivik J, Drabick JJ, Rybka W. Bone Marrow Transplant; 2009 Aug 20; 44(3):157-61. PubMed ID: 19204716 [Abstract] [Full Text] [Related]
57. Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients. Sellner L, Heiss C, Benner A, Raab MS, Hillengass J, Hose D, Lehners N, Egerer G, Ho AD, Goldschmidt H, Neben K. Cancer; 2013 Jul 01; 119(13):2438-46. PubMed ID: 23576287 [Abstract] [Full Text] [Related]
58. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL. Br J Haematol; 2007 Oct 01; 139(2):224-33. PubMed ID: 17897298 [Abstract] [Full Text] [Related]
59. Management of newly diagnosed myeloma. Rajkumar SV, Palumbo A. Hematol Oncol Clin North Am; 2007 Dec 01; 21(6):1141-56, ix-x. PubMed ID: 17996592 [Abstract] [Full Text] [Related]
60. Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients. Krejci M, Hajek R, Buchler T, Krivanova A, Svobodnik A, Pour L, Adam Z, Mayer J, Vorlicek J. Neoplasma; 2007 Dec 01; 54(2):143-8. PubMed ID: 17319788 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]